Control of nuclear HIPK2 localization and function by a SUMO interaction motif

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 2, 2011, Pages 283-297

  de la Vega, Laureano ^a   Fröbius, Katrin ^a   Moreno, Rita ^a   Calzado, Marco A ^b   Geng, Hui ^a   Schmitz, M Lienhard ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Universidad de Cordoba   (Spain)

Author keywords

HIPK2; Nuclear bodies; PML; SIM; SUMO

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; POLYCOMB GROUP PROTEIN; POLYCOMB PROTEIN PC2; PROTEIN HIPK1; PROTEIN HIPK3; PROTEIN SERINE THREONINE KINASE; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CONJUGATION; COVALENT BOND; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BLOTTING, WESTERN; BONE NEOPLASMS; CARRIER PROTEINS; CELL NUCLEUS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRANUCLEAR INCLUSION BODIES; KIDNEY; LUCIFERASES; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN;

EID: 78650957031     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.11.022     Document Type: Article

References (37)

1. Wilkinson K.A., Henley J.M. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 2010, 428:133-145.
2. Geoffroy M.C., Hay R.T. An additional role for SUMO in ubiquitin-mediated proteolysis. Nat. Rev. Mol. Cell Biol. 2009, 10:564-568.
3. Walker D. Sumoylation: wrestling with filaments. Nat. Rev. Mol. Cell Biol. 2010, 11:3.
4. Hecker C.M., Rabiller M., Haglund K., Bayer P., Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 2006, 281:16117-16127.
5. Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl Acad. Sci. USA 2004, 101:14373-14378.
6. Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep 2007, 8:550-555.
7. Calzado M.A., Renner F., Roscic A., Schmitz M.L. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007, 6:139-143.
8. Kim Y.H., Choi C.Y., Lee S.J., Conti M.A., Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 1998, 273:25875-25879.
9. Rinaldo C., Prodosmo A., Siepi F., Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem. Cell Biol. 2007, 85:411-418.
10. Rui Y., Xu Z., Lin S., Li Q., Rui H., Luo W., Zhou H.M., Cheung P.Y., Wu Z., Ye Z., Li P., Han J., Lin S.C. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J. 2004, 23:4583-4594.
11. Gresko E., Roscic A., Ritterhoff S., Vichalkovski A., del Sal G., Schmitz M.L. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J. 2006, 25:1883-1894.
12. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., Piaggio G., Fanciulli M., Appella E., Soddu S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 2002, 4:11-19.
13. Hofmann T.G., Moller A., Sirma H., Zentgraf H., Taya Y., Droge W., Will H., Schmitz M.L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 2002, 4:1-10.
14. Boucher M.J., Simoneau M., Edlund H. The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1/pancreatic duodenal homeobox-1 transcriptional activity. Endocrinology 2009, 150:87-97.
15. Nardinocchi L., Puca R., Sacchi A., Rechavi G., Givol D., D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS ONE 2009, 4:e6819.
16. Calzado M.A., de la Vega L., Moller A., Bowtell D.D., Schmitz M.L. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat. Cell Biol. 2009, 11:85-91.
17. Isono K., Nemoto K., Li Y., Takada Y., Suzuki R., Katsuki M., Nakagawara A., Koseki H. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol. Cell. Biol. 2006, 26:2758-2771.
18. Wei G., Ku S., Ma G.K., Saito S., Tang A.A., Zhang J., Mao J.H., Appella E., Balmain A., Huang E.J. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc. Natl Acad. Sci. USA 2007, 104:13040-13045.
19. Moller A., Sirma H., Hofmann T.G., Rueffer S., Klimczak E., Droge W., Will H., Schmitz M.L. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res. 2003, 63:4310-4314.
20. Rinaldo C., Siepi F., Prodosmo A., Soddu S. HIPKs: Jack of all trades in basic nuclear activities. Biochim. Biophys. Acta 2008, 1783:2124-2129.
21. Pierantoni G.M., Rinaldo C., Mottolese M., Di Benedetto A., Esposito F., Soddu S., Fusco A. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J. Clin. Invest. 2007, 117:693-702.
22. Hofmann T.G., Jaffray E., Stollberg N., Hay R.T., Will H. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J. Biol. Chem. 2005, 280:29224-29232.
23. Gresko E., Moller A., Roscic A., Schmitz M.L. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem. Biophys. Res. Commun. 2005, 329:1293-1299.
24. Roscic A., Moller A., Calzado M.A., Renner F., Wimmer V.C., Gresko E., Ludi K.S., Schmitz M.L. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol. Cell 2006, 24:77-89.
25. Kim Y.H., Choi C.Y., Kim Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl Acad. Sci. USA 1999, 96:12350-12355.
26. Gresko E., Ritterhoff S., Sevilla-Perez J., Roscic A., Frobius K., Kotevic I., Vichalkovski A., Hess D., Hemmings B.A., Schmitz M.L. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene 2009, 28:698-708.
27. Kagey M.H., Melhuish T.A., Powers S.E., Wotton D. Multiple activities contribute to Pc2 E3 function. EMBO J. 2005, 24:108-119.
28. Brackertz M., Boeke J., Zhang R., Renkawitz R. Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3. J. Biol. Chem. 2002, 277:40958-40966.
29. Kalderon D., Roberts B.L., Richardson W.D., Smith A.E. A short amino acid sequence able to specify nuclear location. Cell 1984, 39:499-509.
30. Bischof O., Kirsh O., Pearson M., Itahana K., Pelicci P.G., Dejean A. Deconstructing PML-induced premature senescence. EMBO J. 2002, 21:3358-3369.
31. Seet B.T., Dikic I., Zhou M.M., Pawson T. Reading protein modifications with interaction domains. Nat. Rev. Mol. Cell Biol. 2006, 7:473-483.
32. Yang S.H., Sharrocks A.D. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif. Mol. Cell. Biol. 2010, 30:2193-2205.
33. Merrill J.C., Melhuish T.A., Kagey M.H., Yang S.H., Sharrocks A.D., Wotton D. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity. PLoS ONE 2010, 5:e8794.
34. Zhu J., Zhu S., Guzzo C.M., Ellis N.A., Sung K.S., Choi C.Y., Matunis M.J. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J. Biol. Chem. 2008, 283:29405-29415.
35. Yang S.H., Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 2004, 13:611-617.
36. Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., Pandolfi P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 2006, 24:331-339.
37. Kim Y.H., Sung K.S., Lee S.J., Kim Y.O., Choi C.Y., Kim Y. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1. FEBS Lett. 2005, 579:6272-6278.